ArticleCureus2026
Evaluating Percutaneous Gallbladder Drainage: 10-Year Outcomes From a Large District General Hospital in the UK.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute cholecystitis (AC) is a common surgical emergency, and early laparoscopic cholecystectomy (LC) is considered the standard treatment. However, some patients are unsuitable for surgery due to advanced age, multiple comorbidities, or poor physiological reserve. In these cases, gallbladder drainage is required, most commonly performed using percutaneous transhepatic gallbladder drainage (PTGBD). This study evaluates the outcome of PTGBD in a large UK District General Hospital (DGH). Methods A retrospective analysis was performed of all patients undergoing PTGBD between November 2013 and December 2023 in a single UK DGH. Data collected included demographics, indications, procedural success, complications, need for reintervention, mortality, and subsequent surgical management. Results A total of 47 patients underwent PTGBD (55.3% male, n=26), 71.7% American Society of Anesthesiologists (ASA) grade 3 (n=34). The main indications were AC (78.7%, n=37) and gallbladder perforation (19.1%, n=9). Technical and clinical success rates were 97.8% (n=46) and 92.3% (n=43), respectively. Thirty-day and 90-day mortality were 2.2% (n=1) and 6.8% (n=3), respectively. Reintervention was required in 43.5% of patients (n=20), and 54% (n=25) experienced unplanned readmission, most commonly due to recurrent cholecystitis or drain-related complications. Conclusion PTGBD is an effective, early source control in high-risk patients with AC, with high success rates and acceptable mortality. However, high rates of reintervention and readmission highlight important limitations of this approach. Its use should depend on local expertise and careful outcome monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.